Nuo Therapeutics, Inc. Selling, General and Administrative Expense
Nuo Therapeutics, Inc. (AURX) reported Selling, General and Administrative Expense of $1.34 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:SellingGeneralAndAdministrativeExpense · last filed 2026-08-14
- Nuo Therapeutics, Inc. selling, general and administrative expense for the quarter ending 2026-06-30 was $1.34M, a 12.05% increase year-over-year.
- Nuo Therapeutics, Inc. selling, general and administrative expense for the quarter ending 2026-03-31 was $1.30M, a 16.93% increase year-over-year.
- Nuo Therapeutics, Inc. selling, general and administrative expense for the quarter ending 2025-12-31 was $1.27M, a 35.19% increase year-over-year.
- Nuo Therapeutics, Inc. selling, general and administrative expense for the quarter ending 2025-09-30 was $1.17M, a 37.47% increase year-over-year.
- Nuo Therapeutics, Inc. selling, general and administrative expense for fiscal 2025 was $4.73M, a 34.50% increase from fiscal 2024.
- Nuo Therapeutics, Inc. selling, general and administrative expense for fiscal 2024 was $3.52M, a 3.58% decline from fiscal 2023.
- Nuo Therapeutics, Inc. selling, general and administrative expense for fiscal 2023 was $3.65M, a 6.95% increase from fiscal 2022.
- Nuo Therapeutics, Inc. selling, general and administrative expense for fiscal 2022 was $3.41M, a 3664.89% increase from fiscal 2021.
| Period end | Selling, General and Administrative Expense 3 month | Selling, General and Administrative Expense 6 month | Selling, General and Administrative Expense 9 month | Selling, General and Administrative Expense 12 month |
|---|---|---|---|---|
| 2026-06-30 | $1.34M 10-Q · filed 2026-08-14 | $2.63M 10-Q · filed 2026-08-14 | $3.90M derived: sum of 3 quarters · filed 2026-08-14 | $5.07M derived: sum of 4 quarters · filed 2026-08-14 |
| 2026-03-31 | $1.30M 10-Q · filed 2026-05-14 | $2.56M derived: sum of 2 quarters · filed 2026-05-14 | $3.73M derived: sum of 3 quarters · filed 2026-05-14 | $4.92M derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-12-31 | $1.27M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | $2.43M derived: sum of 2 quarters · filed 2026-03-30 | $3.63M derived: sum of 3 quarters · filed 2026-08-14 | $4.73M 10-K · filed 2026-03-30 |
| 2025-09-30 | $1.17M 10-Q · filed 2025-10-30 | $2.36M derived: sum of 2 quarters · filed 2026-08-14 | $3.47M 10-Q · filed 2025-10-30 | $4.40M derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-06-30 | $1.19M 10-Q · filed 2026-08-14 | $2.30M 10-Q · filed 2026-08-14 | $3.24M derived: sum of 3 quarters · filed 2026-08-14 | $4.09M derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-03-31 | $1.11M 10-Q · filed 2026-05-14 | $2.05M derived: sum of 2 quarters · filed 2026-05-14 | $2.89M derived: sum of 3 quarters · filed 2026-05-14 | $3.74M derived: sum of 4 quarters · filed 2026-05-14 |
| 2024-12-31 | $937.69K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | $1.79M derived: sum of 2 quarters · filed 2026-03-30 | $2.63M derived: sum of 3 quarters · filed 2026-03-30 | $3.52M 10-K · filed 2026-03-30 |
| 2024-09-30 | $847.82K 10-Q · filed 2025-10-30 | $1.69M derived: sum of 2 quarters · filed 2025-10-30 | $2.58M 10-Q · filed 2025-10-30 | $3.39M derived: sum of 4 quarters · filed 2025-10-30 |
| 2024-06-30 | $841.42K 10-Q · filed 2025-07-31 | $1.73M 10-Q · filed 2025-07-31 | $2.54M derived: sum of 3 quarters · filed 2025-07-31 | $3.51M derived: sum of 4 quarters · filed 2025-07-31 |
| 2024-03-31 | $893.23K 10-Q · filed 2025-04-30 | $1.70M derived: sum of 2 quarters · filed 2025-04-30 | $2.67M derived: sum of 3 quarters · filed 2025-04-30 | $3.64M derived: sum of 4 quarters · filed 2025-04-30 |
| 2023-12-31 | $807.75K derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-01 | $1.78M derived: sum of 2 quarters · filed 2025-04-01 | $2.74M derived: sum of 3 quarters · filed 2025-04-01 | $3.65M 10-K · filed 2025-04-01 |
| 2023-09-30 | $967.98K 10-Q · filed 2024-11-12 | $1.94M derived: sum of 2 quarters · filed 2024-11-12 | $2.84M 10-Q · filed 2024-11-12 | $3.87M derived: sum of 4 quarters · filed 2024-11-12 |
| 2023-06-30 | $969.11K 10-Q · filed 2024-08-12 | $1.87M 10-Q · filed 2024-08-12 | $2.90M derived: sum of 3 quarters · filed 2024-08-12 | $3.84M derived: sum of 4 quarters · filed 2024-08-12 |
| 2023-03-31 | $905.87K 10-Q · filed 2024-05-15 | $1.93M derived: sum of 2 quarters · filed 2024-05-15 | $2.87M derived: sum of 3 quarters · filed 2024-05-15 | $3.80M derived: sum of 4 quarters · filed 2024-05-15 |
| 2022-12-31 | $1.02M derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-19 | $1.97M derived: sum of 2 quarters · filed 2024-04-19 | $2.89M derived: sum of 3 quarters · filed 2024-04-19 | $3.41M 10-K · filed 2024-04-19 |
| 2022-09-30 | $943.62K 10-Q · filed 2023-11-20 | $1.87M derived: sum of 2 quarters · filed 2023-11-20 | $2.39M 10-Q · filed 2023-11-20 | $2.46M derived: sum of 4 quarters · filed 2023-11-20 |
| 2022-06-30 | $923.73K 10-Q · filed 2023-08-14 | $1.45M 10-Q · filed 2023-08-14 | $1.52M derived: sum of 3 quarters · filed 2023-08-14 | $1.52M derived: sum of 4 quarters · filed 2023-08-14 |
| 2022-03-31 | $521.82K 10-Q · filed 2023-05-15 | $593.47K derived: sum of 2 quarters · filed 2023-05-15 | $600.22K derived: sum of 3 quarters · filed 2023-05-15 | $606.77K derived: sum of 4 quarters · filed 2023-05-15 |
| 2021-12-31 | $71.65K derived: 10-K 12 month − 10-Q 9 month · filed 2023-04-17 | $78.40K derived: sum of 2 quarters · filed 2023-04-17 | $84.95K derived: sum of 3 quarters · filed 2023-04-17 | $90.67K 10-K · filed 2023-04-17 |
| 2021-09-30 | $6.75K 10-Q · filed 2022-11-04 | $13.30K derived: sum of 2 quarters · filed 2022-11-04 | $19.02K 10-Q · filed 2022-11-04 | |
| 2021-06-30 | $6.55K 10-Q/A · filed 2022-08-10 | $12.27K 10-Q/A · filed 2022-08-10 | ||
| 2021-03-31 | $5.72K 10-Q · filed 2022-05-16 | |||
| 2020-09-30 | $6.25K 10-Q · filed 2022-11-04 | $54.42K 10-Q · filed 2022-11-04 |